Dr. Aung has 20 years of experience in the biotechnology and pharmaceutical industry and has led oncology-focused clinical development teams and projects, according to a Feb. 3 news release from the company.
In her new role, Dr. Aung will lead the development of several Ambrx product candidates.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
